Skip to content

A clinical trial on chitramanakku ilai chooranam in the management of ceganavatham(cervical spondylosis)

A PROSPECTIVE OPEN LABELLED SINGLE ARM NON RANDOMIZED SINGLE CENTRIC PHASE II CLINICAL TRIAL ON CHITRAMANAKKU ILAI CHOORANAM IN THE MANAGEMENTOF CEGANAVATHAM(CERVICAL SPONDYLOSIS)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052605
Enrollment
40
Registered
2023-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

Intervention1: CHITRAMANAKKU ILAI CHOORANAM: 2mg Twice a day (orally) Honey/Ghee 45days Control Intervention1: NIL: NIL

Sponsors

Government Siddha Medical college and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Neck pain radiating to upper limb with or without numbness, giddiness and neck stiffness 2.Restriction neck movements. 3.Willing for doing laboratory investigations and X-Ray imaging. 4.The neck disability Index score should be equal or greater than 40%

Exclusion criteria

Exclusion criteria: 1.Age : Below 20 Years, Above 60 years 2.Traumatic injury 3.Systemic hypertension 4.Ischemic heart diseases 5.Chronic kidney disease 6.Tuberculosis in spine 7.Secondary malignancy 8.Chronic systemic illness 9.Congenital spinal anomalies

Design outcomes

Primary

MeasureTime frame
Reduction of the symptoms of pain in neck and upper limbs Improvement of the range of movements in the neck and upper limb The outcome is aimed at reducing pain and increasing the range of movements Good improvement-score10%below10% Moderate improvement-score10-20% Mild improvement-score20-30% No improvement-score40%Timepoint: 45 days

Secondary

MeasureTime frame
To evaluate the physicochemical,phytochemicals,biochemical analysis of clinical trial drug To evaluate the safety profile for acute and subacute toxicity of the trial drug To evaluate Antimicrobial activity of the trial drug To evaluate the pharmacological analysis of the clinical trial drug To evaluate siddha parameters and compare the (including envagaithervu)changes in ceganavatham during trial period To evaluate modern parametric changes in ceganavatham To evaluate the efficacy of chitramanakku ilai chooranam on ceganavatham by the bio statistical analysisTimepoint: 45 days

Countries

India

Contacts

Public ContactProf Dr A Manoharan MDs PhD

Government Siddha Medical College and Hospital,Palayamkottai

sukgsmc2014@gmail.com8072685509

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026